A docking station receives an enteral feeding pump or food pod into a cradle with a scales platform. The docking station is calibrated to determine nutritional data consumption and remaining available food on the basis of remaining food weight and nutritional data read from a tag using NFC. The station has a sealing sleeve with a sealing rim to confine any spillages in a manner which does not affect weight of the device on a weighting platform.

The package comprises a sterile bag filled with liquid diluent, a bottle equipped with a pierceable cap to contain a medicinal substance and a tube extending from the bag and having a coupling and perforation device for the cap. The bag is housed in a first casing, while the bottle and the coupling and perforation device are in a second casing. The tube has a portion, housing a flow diverter adjustable from a first position which impedes any communication between the bottle and the bag, a second position which allows the bag to be put in communication with a sealed side opening for a syringe, or a third position which allows the bottle to be connected with said side opening. Another side opening of the flow diverter a flexible tube with hydrophobic filter is attached, terminating into one of said sterile sealed casings and serving as a pressure compensator.

Methods and apparatus for an enteral feeding pump system. A method of directing flow for a coil includes drawing fluid from a source and delivering fluid, the coil including input and output check valves to prevent a back flow of fluid.

Enteral safety system (ESS) may include syringe having visual indicator such as barrel with measurement marks of a color. Barrel may allow content viewing. ESS may include hub for connecting syringe to enteral set. Hub may have a visual indicator such as being same color as barrel's marks. Enteral tubing or set may have a visual indicator such as a lengthwise stripe same color as barrel's marks. Enteral tubing may allow content viewing. ESS may include an enteral tubing-feeding tube hub for connecting enteral tubing to a feeding tube. This hub may have visual indicator such as same color as barrel's marks. Feeding tube may have visual indicator such as a lengthwise stripe same color as barrel's marks. Feeding tube may allow content viewing. The syringe, syringe-enteral tubing hub, enteral tubing, enteral tubing-feeding tube hub, and feeding tubing are properly connectable by reference to visual indicators such as color matching.

An improved oral administration coupler for delivery of fluids such as medications and nutritional fluids. Example oral administration couplers have a first end with an applicator for oral delivery to an infant, and a second end with a coupling compatible with an enteral fluid delivery syringe. A fluid delivery conduit extends in fluid communication from the first end to the second end, to deliver fluid from the syringe to the infant. In some example embodiments, the coupler is configured for back-of-mouth delivery, and can comprise a generally elongate and at least partially flexible tube or straw.

A male to female coupling for attachment between a connector of an enteral fluid delivery assembly and a connector of a syringe. In example embodiments, the male to female coupling comprises an annular space for collection of unused feeding fluids.

A system to provide active agent (e.g., scent molecules) includes a delivery system that may include a reservoir, an actuator (e.g., nebulizer), and a fluidly communicative scent path through which a vapor or aerosol may be supplied or dispensed, the vapor or aerosol comprising readily-soluble droplets having a median size range of approximately 2 microns to approximately 50, 20, or 10 microns for introduction to an animal via a retro-nasal route. The vapor or aerosol may be dispensed below a top of the vessel, in a direction that at least initially retains the vapor or aerosol in the vessel. The system may include a base to support or secure the vessel, a cover to close the vessel, and, or a conduit or straw to sip from the vessel. The system can include switches or sensors to provide signals to control operation of the actuator, for instance, based on position, orientation, or direct or indirect user input. The system takes the form of conduit, e.g., straw or stirrer.

Enteral safety system (ESS) may include syringe having visual indicator such as barrel with measurement marks of a color. Barrel may allow content viewing. ESS may include hub for connecting syringe to enteral set. Hub may have a visual indicator such as being same color as barrel's marks. Enteral tubing or set may have a visual indicator such as a lengthwise stripe same color as barrel's marks. Enteral tubing may allow content viewing. ESS may include an enteral tubing-feeding tube hub for connecting enteral tubing to a feeding tube. This hub may have visual indicator such as same color as barrel's marks. Feeding tube may have visual indicator such as a lengthwise stripe same color as barrel's marks. Feeding tube may allow content viewing. The syringe, syringe-enteral tubing hub, enteral tubing, enteral tubing-feeding tube hub, and feeding tubing are properly connectable by reference to visual indicators such as color matching.

A completely wireless capnography/drug delivery system is provided, with the drug delivery device reacting in relation to raw data transfers from the capnography device. Such a system utilizes the same capnography waveform generating algorithm within each component device (including an external connectivity base and a possible data center, as well) to receive raw data for comparison waveform results to ensure system functionality and to prevent outside data compromise or hacking. If an alert as to subject patient capnography waveform results initially at the capnography device, the other system component devices are alerted and such raw data is then transferred for such mirror capnography waveform generation at each location. Such a system thus allows for the drug delivery device to provide needed drug delivery operations directly, and wirelessly, in relation to such capnography waveform results, allowing the subject patient full mobility while monitored and treated.

A formulation comprising platelet rich plasma (PRP) for treatment of patients who have experienced brain injury, consisting of: a mixture of human plasma composed of pluripotent adult stem cells comprising very small embryonic like stem cells from autologous plasma or allogeneic plasma, D5W, glutathione, methylcobalamin, and regular insulin. The formulation is infused directly adjacent to a patient's brain through the nostrils or nares of the nasal cavity. Treatment using the formulation may be supplemented with one or more therapies including hyperbaric oxygen therapy (HBOT), cranial osteopathic therapy, intravenous (IV) nutrition, electroencephalographic (EEG) biofeedback, low level laser therapy (LLLT), transcranial magnetic stimulation (TMS), additional PRP pluripotent adult stem cell treatments, and a ketogenic diet and medium-chain triglyceride (MCT) oil therapy.